Furthermore, it was reported that GSK3β inhibitors may selectively kill cancer cells overexpressing GLUT3 while barely affecting cells expressing only GLUT1.Thus, GLUT3 inhibitors may also exhibit selective elimination of PMN-MDSCs 42, however relevant studies have not been confirmed. The gene discussed is SLC2A3; the disease is cancer.